112 related articles for article (PubMed ID: 9626119)
1. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis.
Heshmati HM; Khosla S; Burritt MF; O'Fallon WM; Riggs BL
J Clin Endocrinol Metab; 1998 Jun; 83(6):1916-20. PubMed ID: 9626119
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
McKane WR; Khosla S; Burritt MF; Kao PC; Wilson DM; Ory SJ; Riggs BL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3458-64. PubMed ID: 8530583
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.
Eastell R; Calvo MS; Burritt MF; Offord KP; Russell RG; Riggs BL
J Clin Endocrinol Metab; 1992 Mar; 74(3):487-94. PubMed ID: 1740481
[TBL] [Abstract][Full Text] [Related]
4. Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women.
Dick IM; Devine A; Beilby J; Prince RL
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E430-5. PubMed ID: 15466921
[TBL] [Abstract][Full Text] [Related]
5. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism.
Sakhaee K; Nicar MJ; Glass K; Pak CY
J Clin Endocrinol Metab; 1985 Aug; 61(2):368-73. PubMed ID: 4008611
[TBL] [Abstract][Full Text] [Related]
7. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.
Nordin BE; Need AG; Morris HA; Horowitz M
Osteoporos Int; 1999; 9(4):351-7. PubMed ID: 10550453
[TBL] [Abstract][Full Text] [Related]
8. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
Tsai KS; Ebeling PR; Riggs BL
J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
[TBL] [Abstract][Full Text] [Related]
9. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
Cosman F; Shen V; Herrington B; Lindsay R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
[TBL] [Abstract][Full Text] [Related]
10. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
11. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
Horm Metab Res; 1994 Jan; 26(1):39-42. PubMed ID: 8150422
[TBL] [Abstract][Full Text] [Related]
12. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
13. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
Deal C; Omizo M; Schwartz EN; Eriksen EF; Cantor P; Wang J; Glass EV; Myers SL; Krege JH
J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
[TBL] [Abstract][Full Text] [Related]
14. [Increase of PTH in post-menopausal osteoporosis].
Cerdà D; Peris P; Monegal A; Albaladejo C; Martínez de Osaba MJ; Surís X; Guañabens N
Rev Clin Esp; 2011; 211(7):338-43. PubMed ID: 21596374
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
16. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
18. Renal leak of calcium in post-menopausal osteoporosis.
Nordin BE; Horowitz M; Need A; Morris HA
Clin Endocrinol (Oxf); 1994 Jul; 41(1):41-5. PubMed ID: 8050130
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid function in relation to intestinal function and renal calcium reabsorption in patients with nephrolithiasis.
Lindsjö M; Danielson BG; Fellström B; Norheim I; Wide L; Ljunghall S
Scand J Urol Nephrol; 1992; 26(1):55-64. PubMed ID: 1631508
[TBL] [Abstract][Full Text] [Related]
20. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
Heshmati HM; Riggs BL; Burritt MF; McAlister CA; Wollan PC; Khosla S
J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
